These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 29055406)

  • 1. The role of soluble epoxide hydrolase in preeclampsia.
    Santos JM; Park JA; Joiakim A; Putt DA; Taylor RN; Kim H
    Med Hypotheses; 2017 Oct; 108():81-85. PubMed ID: 29055406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
    Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
    J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.
    Yu Z; Xu F; Huse LM; Morisseau C; Draper AJ; Newman JW; Parker C; Graham L; Engler MM; Hammock BD; Zeldin DC; Kroetz DL
    Circ Res; 2000 Nov; 87(11):992-8. PubMed ID: 11090543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.
    Imig JD; Zhao X; Capdevila JH; Morisseau C; Hammock BD
    Hypertension; 2002 Feb; 39(2 Pt 2):690-4. PubMed ID: 11882632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels.
    Fang X; Weintraub NL; McCaw RB; Hu S; Harmon SD; Rice JB; Hammock BD; Spector AA
    Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2412-20. PubMed ID: 15284062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble epoxide hydrolase contamination of specific catalase preparations inhibits epoxyeicosatrienoic acid vasodilation of rat renal arterioles.
    Gauthier KM; Olson L; Harder A; Isbell M; Imig JD; Gutterman DD; Falck JR; Campbell WB
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F765-72. PubMed ID: 21753077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.
    Fang X; Hu S; Xu B; Snyder GD; Harmon S; Yao J; Liu Y; Sangras B; Falck JR; Weintraub NL; Spector AA
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H55-63. PubMed ID: 16113065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoxyeicosatrienoic acid pathway in human health and diseases.
    Bellien J; Joannides R
    J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Soluble Epoxide Hydrolase in Human Gestational Tissues from Pregnancies Complicated by Acute Chorioamnionitis.
    Hung TH; Chen SF; Wu CH; Kao CC; Wu CP
    Mediators Inflamm; 2019; 2019():8687120. PubMed ID: 31885501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition.
    Fang X; Kaduce TL; Weintraub NL; Harmon S; Teesch LM; Morisseau C; Thompson DA; Hammock BD; Spector AA
    J Biol Chem; 2001 May; 276(18):14867-74. PubMed ID: 11278979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins.
    Yang T; Peng R; Guo Y; Shen L; Zhao S; Xu D
    Lipids Health Dis; 2013 Oct; 12():151. PubMed ID: 24148690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EET-dependent potentiation of pulmonary arterial pressure: sex-different regulation of soluble epoxide hydrolase.
    Kandhi S; Qin J; Froogh G; Jiang H; Luo M; Wolin MS; Huang A; Sun D
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1478-86. PubMed ID: 26498250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.
    Jiang H; Quilley J; Doumad AB; Zhu AG; Falck JR; Hammock BD; Stier CT; Carroll MA
    Am J Physiol Heart Circ Physiol; 2011 Jun; 300(6):H1990-6. PubMed ID: 21398593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral delivery of 1,3-dicyclohexylurea nanosuspension enhances exposure and lowers blood pressure in hypertensive rats.
    Ghosh S; Chiang PC; Wahlstrom JL; Fujiwara H; Selbo JG; Roberds SL
    Basic Clin Pharmacol Toxicol; 2008 May; 102(5):453-8. PubMed ID: 18312493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation.
    Duflot T; Pereira T; Roche C; Iacob M; Cardinael P; Hamza NE; Thuillez C; Compagnon P; Joannidès R; Lamoureux F; Bellien J
    Anal Bioanal Chem; 2017 Mar; 409(7):1845-1855. PubMed ID: 27981341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase.
    Widstrom RL; Norris AW; Van Der Veer J; Spector AA
    Biochemistry; 2003 Oct; 42(40):11762-7. PubMed ID: 14529287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated 14,15- epoxyeicosatrienoic acid by increasing of cytochrome P450 2C8, 2C9 and 2J2 and decreasing of soluble epoxide hydrolase associated with aggressiveness of human breast cancer.
    Wei X; Zhang D; Dou X; Niu N; Huang W; Bai J; Zhang G
    BMC Cancer; 2014 Nov; 14():841. PubMed ID: 25406731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients.
    Duflot T; Moreau-Grangé L; Roche C; Iacob M; Wils J; Rémy-Jouet I; Cailleux AF; Leuillier M; Renet S; Li D; Morisseau C; Lamoureux F; Richard V; Prévost G; Joannidès R; Bellien J
    Cardiovasc Diabetol; 2019 Mar; 18(1):35. PubMed ID: 30885203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
    Sharkey LC; Radin MJ; Heller L; Rogers LK; Tobias A; Matise I; Wang Q; Apple FS; McCune SA
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):47-57. PubMed ID: 23993975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mechanism of ascorbate direct modulation of soluble epoxide hydrolase.
    Zhang B; Kandhi S; Yang YM; Le Y; Deng W; Qin J; Jiang H; Froogh G; Sun D; Huang A
    Prostaglandins Other Lipid Mediat; 2017 Jul; 131():59-66. PubMed ID: 28827137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.